Page last updated: 2024-08-17

bromodeoxyuridine and Lymphoma, Large-Cell, Anaplastic

bromodeoxyuridine has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basso, G; Bonvini, P; Monaco, G; Mussolin, L; Pigazzi, M; Rosolen, A; Zorzi, E	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Lymphoma, Large-Cell, Anaplastic

Article	Year
The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity. Haematologica, 2009, Volume: 94, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Separation; Cell Survival; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large-Cell, Anaplastic; Piperidines; Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Subcellular Fractions; Time Factors	2009

Article

Year

The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity.

Haematologica, 2009, Volume: 94, Issue:7

Topics: Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Separation; Cell Survival; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large-Cell, Anaplastic; Piperidines; Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Subcellular Fractions; Time Factors

2009